2,4-diaminoquinazoline has been researched along with 1-aminoisoquinoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estiarte, A; Gjerstad, E; Graupe, M; Green, MJ; Hirschbein, B; Ho, JD; Janc, JW; Katz, BA; Lee, CS; Lehoux, I; Liu, L; Liu, Y; McGrath, ME; Somoza, JR; Spencer, J; Sperandio, D; Sprengeler, PA; Tai, V; Venkataramani, C; Yee, R | 1 |
| Ackermann, B; Erdel, V; Ferner, J; Göbel, MW; Kalden, E; Scheffer, U; Schwalbe, H; Shoja-Bazargani, F; Stark, S; Zeiger, M | 1 |
2 other study(ies) available for 2,4-diaminoquinazoline and 1-aminoisoquinoline
| Article | Year |
|---|---|
Structure-guided design of peptide-based tryptase inhibitors.
Topics: Crystallography, X-Ray; Models, Molecular; Protein Conformation; Serine Endopeptidases; Serine Proteinase Inhibitors; Tryptases | 2006 |
Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.
Topics: Amino Acid Sequence; Base Sequence; Binding Sites; HIV Long Terminal Repeat; HIV-1; Humans; Ligands; Magnetic Resonance Spectroscopy; Nucleic Acid Conformation; RNA, Viral; Small Molecule Libraries; tat Gene Products, Human Immunodeficiency Virus | 2014 |